Avidity Biosciences Set to Engage with Investors at Key Conferences in September
Avidity Biosciences Engaging Investors in September 2025
Avidity Biosciences, Inc., a leading biopharmaceutical firm dedicated to pioneering a new frontier in RNA therapeutics through its innovative Antibody Oligonucleotide Conjugates (AOCs™), is gearing up for a packed September with several prominent investor conferences. The company is ready to showcase its latest advancements in RNA therapeutics and engage with the investor community to discuss their groundbreaking work in this field.
Upcoming Conference Schedule
Starting with the Cantor Global Healthcare Conference 2025 in New York, Avidity's management team will participate in a fireside chat on September 3, 2025, at 7:20 AM PT | 10:20 AM ET. This inaugural event will kick off a series of discussions aimed at highlighting the company's recent progress and future plans.
Following that, on September 4, 2025, the team will present at the 2025 Wells Fargo Healthcare Conference in Everett, MA, at 9:45 AM PT | 12:45 PM ET. This conference continues to be a pivotal platform for biopharmaceutical companies to connect with potential investors and stakeholders.
Lastly, the Morgan Stanley 23rd Annual Global Healthcare Conference will feature Avidity on September 8, 2025, at 10:50 AM PT | 1:50 PM ET. These engagements promise to provide insights into Avidity's strategic objectives and updates on their clinical pipeline.
Live Webcasts and Archive Access
For those unable to attend the live events, Avidity has made arrangements for live webcasts of each conference, which will be accessible through their
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.